Skip to main content
. 2017 Nov 28;1(25):2421–2432. doi: 10.1182/bloodadvances.2017009449

Figure 2.

Figure 2.

Method for allogeneic BMT of humanized CA mice in the absence of cytoreductive conditioning. Donor total BMCs from GFP transgenic mice were treated with Diprotin A and injected intravenously into 3-day-old humanized CA recipients that received a single injection of anti-CD122 antibody on day 2 after birth. Transplanted CA mice were analyzed across time for rescue from lethal anemia, hematology, growth velocity, fertility, hematopoietic chimerism, and GVHD.